KYOTO -- Japanese biotechnology company Takara Bio has developed a method to simultaneously process more than 5,000 polymerase chain reaction tests, which can screen for the new coronavirus, in just under two hours.
Pharmaceuticals
Takara Bio cuts time for 5,000 coronavirus tests to two hours
Japanese biotech company reduces typical 1-day wait for results
Approval is first being sought for the U.S. market, where COVID-19 cases are rapidly growing. (Source photo by Takara Bio)
Read Next
Latest on Pharmaceuticals
